ETFs with LLY: A Comprehensive Guide

LLY is a well-established pharmaceutical company with a strong track record of innovation and growth.

In this guide, we'll explore the top ETFs that offer exposure to LLY, including the SPDR S&P 500 ETF Trust (SPY) which holds approximately 0.35% of its total assets in LLY.

LLY's market capitalization is around $200 billion, making it a significant player in the pharmaceutical industry.

The Vanguard Total Stock Market ETF (VTI) also holds a small stake in LLY, with a weighting of around 0.25% in its portfolio.

Investors looking for a more focused approach can consider the iShares US Pharmaceuticals ETF (IHE), which has a 7.5% weighting in LLY.

Readers also liked: Bear Market Etfs

The Harvest Eli Lilly High Income Shares ETF offers a unique investment opportunity, with units available in both CAD and USD.

The ETF's inception date is August 21, 2024, and it's eligible for various registered retirement savings plans, including RRSP, TFSA, RRIF, RESP, and FHSA.

It's worth noting that the ETF has a medium risk rating.

The Harvest Eli Lilly High Income Shares ETF is an interesting fund that offers a unique approach to generating high income. It provides access to the growth potential of Eli Lilly and overlays an active covered call writing strategy on up to 50% of the position.

The fund is available in both CAD (LLYH) and USD (LLYH.U) units. This means you can choose the currency that suits your needs.

The ETF has a medium risk rating, which is a good thing if you're looking for a balance between potential returns and risk. The distribution frequency is monthly, and the distribution method is cash or DRIP (Dividend Reinvestment Plan).

Here's a brief overview of the ETF's key facts:

The Historical Price of a fund is an essential piece of information for investors. It tells you the current market value of the fund's shares.

The ticker symbol for the LLY fund is LLYH, and its reference asset is LLY.

The fund distributes $0.16 per unit each month, which is a significant aspect of its pricing.

Here's a breakdown of the fund's current price:

The fund's management fee is a reasonable 0.40% of its assets under management (AUM).

You might like: Bcbs Utilization Management